Correction Volume 17, Issue 12 pp 3003—3004
Correction for: Combined identification of ARID1A, CSMD1, and SENP3 as effective prognostic biomarkers for hepatocellular carcinoma
- 1 Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
- 2 Key Laboratory of Organ Transplantation, Ministry of Education, Wuhan 430030, China
- 3 NHC Key Laboratory of Organ Transplantation, Wuhan 430030, China
- 4 Key Laboratory of Organ Transplantation, Chinese Academy of Medical Sciences, Wuhan 430030, China
Received: October 28, 2025 Accepted: December 9, 2025 Published: December 31, 2025
https://doi.org/10.18632/aging.206350How to Cite
Copyright: © 2025 Zhao et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This article has been corrected: The authors identified an error in the assembly of Figure 7A. Specifically, the image of transwell invasion assay intended to represent the siRNC (negative control) group in the SENP3 gene panel was erroneously replaced with the image from the siRNA group. This was an oversight during the figure preparation process.
The Figure 7A SENP3 siRNC panel has been replaced by the authors using data from the original experiments. This correction does not change the conclusions of the publication.
The corrected version of Figure 7 is provided below.
Figure 7. Cell invasion after the suppression of genes, ARID1A, CSMD1, and SENP3 by siRNA. The images of transwell invasion assay shown in (A) were scanned, quantified, and plotted in (B–D, respectively).